Magda Tsaneva

Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey

Research gaps in psoriasis: Opportunities for future studies

Revisiting comorbidities in gout: a cluster analysis

Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk

Psoriasis prevalence among adults in the United States

Increased Suicide Risk in Patients with Hidradenitis Suppurativa

Psoriasis Outcome Measures: A Report from the GRAPPA 2012 Annual Meeting

The Prevalence and Odds of Depressive Symptoms and Clinical Depression in Psoriasis Patients: A Systematic Review and Meta-Analysis

Psoriasis

Gout

The economic burden of gout: A systematic review

Psoriasis and risk of diabetes-associated microvascular and macrovascular complications

Hidradenitis suppurativa

Ulcerative colitis

Recommendations for detection of individual risk for comorbidities in patients with psoriasis

Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–2016

Psoriasis Pathogenesis and Treatment

Gout

Reliability and validity of the Psoriasis Itch Visual Analog Scale in psoriasis vulgaris

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

Risks of developing psychiatric disorders in pediatric patients with psoriasis

The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis

Comorbidity Burden, Healthcare Resource Utilization, and Costs in Chronic Gout Patients Refractory to Conventional Urate-Lowering Therapy

Economic burden of comorbidities in patients with psoriasis is substantial